Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 41, pseudogene (RNU1-41P) is a human genetic locus annotated as a pseudogene of the U1 small nuclear RNA (snRNA) family. It bears sequence similarity to canonical U1 small nuclear RNA genes but has accumulated mutations rendering it non-functional; such pseudogenes do not yield a functional snRNA product and do not contribute to spliceosomal activity. The canonical U1 snRNA plays a central role in pre-mRNA splicing by guiding spliceosome assembly, but RNU1-41P is not believed to participate in any functional RNA or disease-related mechanism. There is no evidence that RNU1-41P serves as a therapeutic target, nor does it appear as a biomarker or drug interaction node[1]. Note: - This entry is classified as a pseudogene, which, by definition, does not encode an active gene product and is not considered a therapeutic target[1]. - Functional information found for canonical U1 snRNA (e.g., RNU1-1) does not apply to this pseudogene variant[1][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 41, pseudogene (RNU1-41P).